Skip to main content

Xu Cheryl's Form 4 filing

60 Degrees Pharmaceuticals, Inc.SXTP · filed Feb 2, 2024

Accession no.
0001213900-24-009599
Filed
Feb 2, 2024, 3:31 PM ET
Trade date
Jan 31-Feb 1, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $75.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Xu CherylCIK 0001976957Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 31, 2024Common StockPPurchaseAcquired+200,000$0.375+$75,000424,934Direct
Feb 1, 2024Common StockMOption exerciseAcquired+2,000–F1–6,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 31, 2024Common StockPPurchaseAcquired+200,000$0.01+$2,000200,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Ms. Xu was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. A total of 8,000 RSUs were granted to Ms. Xu on July 11, 2023 and vest in equal quarterly installments for a period of 12 months. As of the date of this filing, a total of 6,000 RSUs have vested.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)